Torrent Pharmaceuticals Limited (NSE:TORNTPHARM)
India · Delayed Price · Currency is INR 4,045.00
+57.80 (1.45%)
Feb 3, 2026, 3:29 PM IST
Torrent Pharmaceuticals Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Net Income | 21,403 | 19,113 | 16,564 | 12,452 | 7,772 | 12,519 |
Depreciation & Amortization | 7,840 | 7,740 | 7,748 | 6,830 | 6,427 | 6,399 |
Other Amortization | 209.3 | 209.3 | 204.6 | 190.3 | 192.8 | 174 |
Loss (Gain) From Sale of Assets | -43.4 | -13.4 | -883.6 | -216.2 | 8.2 | 13 |
Asset Writedown & Restructuring Costs | - | - | 129.7 | 45.6 | 2.3 | 4.8 |
Loss (Gain) From Sale of Investments | -177.3 | -167.3 | -179.9 | -195.1 | -101.4 | -155.8 |
Provision & Write-off of Bad Debts | 27.7 | 17.7 | 70.8 | 22.7 | 9 | 144.2 |
Other Operating Activities | 1,582 | 3,762 | 4,826 | 4,734 | 7,239 | 4,338 |
Change in Accounts Receivable | -3,478 | 171.7 | 783.2 | -2,897 | -1,091 | 652.1 |
Change in Inventory | -1,952 | -2,622 | -494.3 | 2,557 | 2,189 | -5,330 |
Change in Accounts Payable | -5,197 | -2,777 | 4,136 | -580.2 | -3,924 | 1,295 |
Change in Other Net Operating Assets | -811.9 | 418.1 | -243.6 | 738.3 | -692.5 | - |
Operating Cash Flow | 19,401 | 25,851 | 32,661 | 23,681 | 18,030 | 20,054 |
Operating Cash Flow Growth | -43.09% | -20.85% | 37.92% | 31.34% | -10.09% | 43.97% |
Capital Expenditures | -5,819 | -6,119 | -4,328 | -5,739 | -2,026 | -3,352 |
Sale of Property, Plant & Equipment | 187.7 | 177.7 | 1,337 | 1,587 | 67.9 | 11.3 |
Cash Acquisitions | - | - | - | -20,000 | - | - |
Investment in Securities | -552.1 | 337.9 | 1,181 | -129.8 | -80.9 | -1,207 |
Other Investing Activities | 232.6 | 202.6 | 131.2 | 129 | 72.4 | 52.5 |
Investing Cash Flow | -5,951 | -5,401 | -1,679 | -24,153 | -1,966 | -4,494 |
Short-Term Debt Issued | - | - | - | 8,420 | 2,186 | - |
Long-Term Debt Issued | - | - | - | 13,950 | - | 8,950 |
Total Debt Issued | - | - | - | 22,370 | 2,186 | 8,950 |
Short-Term Debt Repaid | - | -3,963 | -1,334 | - | - | -3,789 |
Long-Term Debt Repaid | - | -5,564 | -12,599 | -9,936 | -10,651 | -14,724 |
Total Debt Repaid | -5,317 | -9,527 | -13,933 | -9,936 | -10,651 | -18,513 |
Net Debt Issued (Repaid) | -5,317 | -9,527 | -13,933 | 12,434 | -8,464 | -9,563 |
Common Dividends Paid | -10,830 | -10,830 | -10,153 | -5,132 | -6,769 | -3,385 |
Other Financing Activities | -2,942 | -2,622 | -3,710 | -3,030 | -2,577 | -3,561 |
Financing Cash Flow | -19,090 | -22,980 | -27,796 | 773.6 | -17,811 | -16,508 |
Foreign Exchange Rate Adjustments | 392.7 | -87.3 | 80.7 | 211.2 | 5.3 | 56 |
Miscellaneous Cash Flow Adjustments | - | - | - | 588.3 | - | - |
Net Cash Flow | -5,247 | -2,617 | 3,266 | 1,101 | -1,742 | -892.6 |
Free Cash Flow | 13,582 | 19,732 | 28,333 | 17,942 | 16,004 | 16,702 |
Free Cash Flow Growth | -53.63% | -30.35% | 57.92% | 12.11% | -4.18% | 69.37% |
Free Cash Flow Margin | 11.09% | 17.14% | 26.41% | 18.65% | 18.81% | 20.87% |
Free Cash Flow Per Share | 40.13 | 58.30 | 83.72 | 53.01 | 47.29 | 49.35 |
Cash Interest Paid | 2,942 | 2,622 | 3,710 | 3,030 | 2,577 | 3,561 |
Cash Income Tax Paid | 7,398 | 6,028 | 4,981 | 3,981 | 4,210 | 1,755 |
Levered Free Cash Flow | 9,874 | 12,787 | 22,213 | 14,783 | 10,209 | 7,970 |
Unlevered Free Cash Flow | 11,226 | 14,358 | 24,417 | 16,860 | 11,790 | 10,163 |
Change in Working Capital | -11,439 | -4,809 | 4,181 | -182 | -3,519 | -3,383 |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.